Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Acquisition

9 Aug 2017 07:00

RNS Number : 4471N
Scapa Group PLC
09 August 2017
 

 

 

 

 

9 August 2017

 

 

 

Scapa Group plc 

Acquisition of Markel Industries

 

 

 

Scapa Group plc ("Scapa") (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive-based products for the healthcare and industrial markets, is pleased to announce that it has acquired the entire share capital of Markel Industries, Controlled Environment Equipment Corp and CMark Films, LLC (together the "Company" or "Markel") for a total purchase price of USD$10 million.

Markel is a leading North American manufacturer of adhesive floor mats and tacky rollers for use in medical clean rooms, electronic and industrial assembly areas, construction site and sports venues.

As at 31 December 2016, the unaudited gross assets acquired were USD$1.2 million. Underlying adjusted EBITDA for the year ended 31 December 2016 was USD$1.7 million. The acquisition is expected to be earnings enhancing in the first full year and will be funded from existing cash reserves and bank facilities.

The Board believes the acquisition of Markel will give the following benefits:

· Markel's largely North American customer base has a similar profile to Scapa's, offering cross-selling opportunities

· Markel's high quality core clean room contamination prevention products will enhance Scapa's current products offerings in Europe

· Meaningful overlap in supply chain and manufacturing technology as well as proximity of Markel's manufacturing sites to Scapa offer an opportunity for efficiencies

Commenting on the acquisition, Heejae Chae, the Group Chief Executive Officer of Scapa, said:

"The acquisition of Markel is a part of our Industrial strategy to further drive the Return on Capital Employed through concentration on our core customers and markets as well as optimisation of our manufacturing assets."

 

 

For further information:

 

Scapa Group plc

Heejae Chae - Chief Executive

Graham Hardcastle - Finance Director

 

 

 0161 301 7430

Numis Securities Limited

(Nominated Adviser and Joint Broker)

Richard Thomas/Mark Lander

 020 7260 1000

 

Berenberg

(Joint Broker)

Chris Bowman

 

Weber Shandwick Financial PR

Nick Oborne

 

 020 3207 7800

 

 

 

020 7067 0000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBUGDIISGBGRI
Date   Source Headline
1st Mar 201710:22 amRNSAdditional Listing
23rd Feb 201711:03 amRNSHolding(s) in Company
16th Feb 20179:21 amRNSHolding(s) in Company
7th Feb 20174:16 pmRNSBlock listing Interim Review
3rd Feb 20173:53 pmRNSHolding(s) in Company
26th Jan 201710:10 amRNSDirector/PDMR Shareholding
25th Jan 20174:33 pmRNSBlock listing Interim Review
25th Jan 201711:49 amRNSHolding(s) in Company
23rd Jan 20179:18 amRNSDirector/PDMR Shareholding
9th Jan 20179:41 amRNSAdditional Listing
22nd Dec 20162:15 pmRNSAdditional Listing
15th Dec 20167:00 amRNSDirectorate Change
13th Dec 20161:29 pmRNSAdditional Listing
24th Nov 20164:30 pmRNSDirector/PDMR Shareholding
24th Nov 20164:20 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:20 pmRNSAdditional Listing
22nd Nov 20167:00 amRNSHalf-year Report
12th Oct 20167:00 amRNSTrading Statement
27th Sep 20162:53 pmRNSDirector/PDMR Shareholding
21st Sep 20161:51 pmRNSAdditional Listing
6th Sep 201610:24 amRNSAdditional Listing
2nd Sep 201611:20 amRNSBlock listing Interim Review
31st Aug 20169:14 amRNSTotal Voting Rights
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
12th Aug 201611:24 amRNSBlock listing Interim Review
11th Aug 20161:30 pmRNSDirector/PDMR Shareholding
10th Aug 201610:08 amRNSDirector/PDMR Shareholding
19th Jul 20164:58 pmRNSAdditional Listing
19th Jul 20167:00 amRNSAGM Statement
11th Jul 20163:48 pmRNSDirector/PDMR Shareholding
5th Jul 20162:25 pmRNSHolding(s) in Company
1st Jul 20162:58 pmRNSDirector/PDMR Shareholding
1st Jun 20163:49 pmRNSAdditional Listing
1st Jun 20167:00 amRNSAppointment of Joint Broker
24th May 20167:00 amRNSAcquisition
24th May 20167:00 amRNSFinal Results
18th May 201610:01 amRNSAdditional Listing
11th May 201610:45 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSDirectorate Change
14th Apr 20167:00 amRNSTrading Statement
2nd Mar 20169:06 amRNSBlocklisting Interim Review
8th Feb 20169:49 amRNSBlocklisting Interim Review
28th Jan 20167:00 amRNSDirectorate Change
31st Dec 20157:00 amRNSTotal Voting Rights
15th Dec 20159:57 amRNSHolding(s) in Company
14th Dec 20158:26 amRNSHolding(s) in Company
14th Dec 20158:21 amRNSDirector/PDMR Shareholding
8th Dec 201511:46 amRNSHolding(s) in Company
8th Dec 201511:42 amRNSHolding(s) in Company
1st Dec 201510:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.